VERISTRAT
Veristrat is a premier valuation company. It provides high-quality, cost-effective, and end-to-end research and market intelligence solutions applicable across multiple industrial sectors and geographies. They are a valuation and advisory company focused on providing high-end business valuation services, investment, and market research.
VERISTRAT
Industry:
Accounting Advice Consulting Consumer Research Financial Services Legal Market Research
Founded:
2010-01-01
Address:
Pleasanton, California, United States
Country:
United States
Website Url:
http://www.veristrat.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Facebook Sharer Gravatar Profiles Hetzner
Similar Organizations
AVANNIS
AVANNIS guides brokerage firms, banks, and credit unions to understand customer experience through management tools.
Capital Valuation Group
Capital Valuation Group, offers financial consulting and litigation support services, Its services include business advisory and valuation.
China Luxury Advisors
China Luxury Advisors is a China strategy consultant that advises and works collaboratively with luxury and premium brands.
Gradient
Gradient expertise in equity research, forensic accounting, and analysis including publishes reports on generating alpha and managing risk.
Isler
Isler provides forensic accounting, litigation support, audits, estate planning, and tax management services for multiple industries.
Matthiesen Wickert & Lehrer
Matthiesen, Wickert & Lehrer is a subrogation and insurance litigation law firm that provides appropriate tools, resources, and consultancy.
Reed Research
Reed Research provides investigation reports on disability claims, insurance fraud, litigation support, and undercover operations.
Under the Radar Report
Under the Radar Report is a fundamental and technical stock market research firm based in Australia.
Current Employees Featured
Founder
Official Site Inspections
http://www.veristrat.com Semrush global rank: 6.57 M Semrush visits lastest month: 1.05 K
- Host name: mirror-rhel9.linuxfabrik.ch
- IP address: 195.201.96.252
- Location: Berlin Germany
- Latitude: 52.5215
- Longitude: 13.3355
- Timezone: Europe/Berlin
- Postal: 10555
More informations about "Veristrat"
Veristrat - Wikipedia
VeriStrat is a test developed to evaluate patient prognosis and, additionally, predict benefit from cancer treatment by EGFR inhibitors. It is a serum/plasma proteomic test developed using …See details»
IQLungâ„¢ Treatment Guidance Testing for Lung Cancer
The VeriStrat test is a novel blood-based host immune classifier (HIC) for patients with non-small cell lung cancer. Clinical studies have shown that the test is predictive and prognostic of outcomes independent of ECOG performance …See details»
Veristat | Successfully Supporting Clinical Research Trials
A distinct clinical research organization, Veristat stands alone in combining industry-leading expertise with unwavering commitment to scientific integrity.See details»
Serum proteomic test in advanced non-squamous non …
Nov 29, 2016 · VeriStrat is a blood-based proteomic test with predictive and prognostic significance in second-line treatments for non-small cell lung cancer (NSCLC). This trial was designed to investigate the...See details»
Biodesix Announces Two Presentations on Lung Cancer Treatment …
Sep 7, 2023 · Expanded analysis of the VeriStrat ® host immune classifier’s ability to predict immune checkpoint inhibition (ICI) response in patients with advanced stage NSCLC; The …See details»
VeriStrat® has prognostic value in advanced stage …
Oct 18, 2012 · VeriStrat has shown its potential for stratification of unselected, advanced stage NSCLC patients treated in first line with a combination of erlotinib and sorafenib. The epidermal growth factor...See details»
Biodesix Announces Inclusion of VeriStrat in Updated NCCN …
Oct 27, 2014 · Biodesix Inc., a molecular diagnostics company dedicated to advancing precision medicine and improved patient care, today announced that its VeriStrat® blood-based …See details»
The serum-based VeriStrat® test is associated with …
Mar 20, 2018 · The VeriStrat test is a serum proteomic signature originally discovered in non-responders to second line gefitinib treatment and subsequently used to predict differential …See details»
Multivariate Blood Test Can Predict Outcomes for Non …
Apr 6, 2019 · Biodesix, Boulder, Colo, has recently presented new data demonstrating that the company’s VeriStrat test is predictive of outcomes for patients with non-small cell lung cancer (NSCLC) treated with immune …See details»
VeriStrat® Test Identifies Lung Cancer Patients Benefiting from ...
Nov 19, 2010 · About VeriStrat: VeriStrat is a proteomic serum test for patients with advanced NSCLC. The test identifies patients who are likely to have good or poor outcomes after …See details»
Molecular & Translational Biology of the Blood-Based VeriStrat ...
Dec 30, 2022 · INTRODUCTION The blood-based VeriStrat ® proteomic test (VS) predicts patient response to therapy based on the intensities of eight different features in a mass spectrum …See details»
Full article: VeriStrat: a prognostic and/or predictive biomarker for ...
Dec 3, 2013 · VeriStrat is a serum/plasma proteomic test developed using matrix-assisted laser desorption/ionization methodology, aiming at predicting benefit from EGFR treatment.See details»
The clinical role of VeriStrat testing in patients with advanced non ...
May 2, 2019 · VeriStrat (proteomic blood test) is an independent prognostic marker for survival. Patients classified as VeriStrat Good were less likely to die than those classified as VeriStrat …See details»
Assessment of the association of the VeriStrat test with outcomes …
May 20, 2013 · We investigated the association of VeriStrat with outcomes in the NCIC CTG PA.3 randomized phase III trial of G and E vs. G and placebo (P) in pts with advanced PC. …See details»
VeriStrat® has prognostic value in advanced stage NSCLC patients ...
Nov 11, 2012 · The serum proteomic test VeriStrat has been shown to be able to classify advanced non-small cell lung cancer (NSCLC) patients for overall survival (OS) after treatment …See details»
Veristrat® Classifier for Survival and Time to Progression in Non …
We applied an established and commercially available serum proteomic classifier for survival after treatment with erlotinib (VeriStrat ®) in a blinded manner to pre-treatment sera obtained from …See details»
Evaluation of VeriStrat, a serum proteomic test, in the randomized ...
VeriStrat is a serum protein test that utilizes MALDI-TOF mass spectrometry to assign a ‘GOOD' (VS-G) or ‘POOR' (VS-P) classification and has demonstrated prognostic and predictive utility …See details»
Veristrat based stratification of responses to immune checkpoint ...
Background: Veristrat (Biodesix, Boulder, CO) is a blood based proteomic assay that is dominated by inflammatory proteins and is prognostic and predictive in metastatic NSCLC after treatment …See details»
Prognostic role of the VeriStrat test in first line patients with non ...
Mar 1, 2018 · VeriStrat ® is a blood-based test that utilizes matrix-assisted laser desorption/ionization time-of-flight (MALDI ToF) mass spectrometry to assign a binary …See details»
Molecular and translational biology of the blood-based VeriStrat ...
Nov 20, 2023 · The VeriStrat® test (VS) is a blood-based assay that predicts a patient's response to therapy by analyzing eight features in a spectrum obtained from matrix-assisted laser …See details»